Gene · 2288
FKBP4: FKBP prolyl isomerase 4
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. FKBP4: FKBP prolyl isomerase 4. Genes, record 2288. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2288
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q02790 | Peptidyl-prolyl cis-trans isomerase FKBP4 | 459 | 12 | Ensembl, GeneID, HGNC |
Source UniProt
Patents74
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4825362 A1 | 2026-10-21 | 1 | Q02790 | Espacenet |
| EP 4803075 A1 | 2026-09-09 | 1 | Q02790 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3 | Q02790 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4280 | Q02790 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3 | Q02790 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 28479 | Q02790 | Espacenet |
| JP 2025505440 A | 2025-02-26 | 1 | Q02790 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4280 | Q02790 | Espacenet |
| JP 2025009766 A | 2025-01-20 | 92 | Q02790 | Espacenet |
| WO 2025005189 A | 2025-01-02 | 92 | Q02790 | Espacenet |
1 to 10 of 74
See all 74 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,240
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | FKBP4 papers | Newest fiscal year |
|---|---|---|---|
| R01NS073899 | The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function | 12 | 2025 |
| ZIABC011032 | Post-translational modifications of Hsp90 | 8 | 2025 |
| ZIASC010074 | HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction | 8 | 2025 |
| R01NS059690 | Molecular Chaperones and Small Molecules | 7 | 2025 |
| ZIAES090057 | Glucocorticoid Hormone Action | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| P50CA097186 | The Pacific Northwest Prostate Cancer SPORE | 4 | 2025 |
| P30AI027767 | UAB Center for AIDS Research (CFAR) | 3 | 2025 |
| P30AI036214 | San Diego Center for AIDS Research (SD CFAR) | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,240Source NIH's project files
See all 1,240 nih grantsPapers1,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploratory Transcriptomic, Genomic, Pharmacogenomic, and Cellular Evaluation of FKBP4 in Lung Adenocarcinoma. | Biology (Basel) | 2026 | 42792605 | PubTator, text mining | PubMed |
| Abnormally Low Hemoglobin A1c Due to a Heterozygous Alpha-Globin Variant (Hb I; HBA2 c.49A>G, p.Lys17Glu) in a Geriatric Patient. | Cureus | 2026 | 42757138 | PubTator, text mining | PubMed |
| SAV1 in Cooperation With FKBP52 Participates in Implantation. | Adv Sci (Weinh) | 2026 | 42750339 | PubTator, text mining | PubMed |
| Identification of Mitotic Catastrophe-related Prognostic Genes in Lung Adenocarcinoma via Transcriptome Analysis. | J Vis Exp | 2026 | 42631570 | PubTator, text mining | PubMed |
| Metabolism Pathway Blood Proteomic Differences in Lewy Body Dementia Compared to Alzheimer's Disease. | Int J Mol Sci | 2026 | 42589529 | PubTator, text mining | PubMed |
| FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications. | J Biol Chem | 2026 | 42556724 | PubTator, text mining | PubMed |
| NOP2-regulated m5C methylation of FKBP4 in promoting lung adenocarcinoma progression. | Exp Cell Res | 2026 | 42526734 | PubTator, text mining | PubMed |
| Identification of Candidate Biomarkers Associated with Mitochondrial Dysfunction and SUMOylation in Heart Failure Based on Bioinformatics Approaches. | J Vis Exp | 2026 | 42441434 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis identifies key microglial subpopulations and therapeutic targets in Parkinson's disease. | Parkinsonism Relat Disord | 2026 | 42430983 | PubTator, text mining | PubMed |
| Machine learning-driven development of a novel unfolded protein response-related gene signature for predicting lung adenocarcinoma patient prognosis. | BMC Cancer | 2026 | 42401850 | PubTator, text mining | PubMed |
1 to 10 of 1,741
See all 1,741 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/2288
GET https://conductscience.org/api/genes/v1/2288/patents?page=2